← Intervention Library

Foundations

Preventive care

Screening cadence, early detection, and baseline diagnostics before decline is visible.

Nara’s current positionVeterinarian-guided
Evidence briefing

Last reviewed 2026-08-12.

Nara’s evidence view

Veterinary or clinical context

SupportedCanine observational evidenceModerate confidence

The claim we’re evaluating

Veterinary preventive assessment can identify previously unrecognized disease and deliver evidence-based preventive interventions, but current canine evidence does not establish that a generic screening panel or fixed screening frequency itself improves healthspan or lifespan.

Nara’s interpretation

Nara considers preventive veterinary care important, but the category should not be given one undifferentiated scientific score. Screening studies show that apparently healthy dogs—particularly older dogs—can have clinically relevant findings that were not previously recognized. Evidence that finding more abnormalities through a generic panel or a fixed testing cadence itself improves lifespan or healthspan is much less established, so screening, vaccination, dental care, parasite control, and other preventive practices should be rated as separate subclaims.

This is an umbrella assessment. The evidence differs materially depending on the outcome and the specific form of the intervention, so Nara evaluates those narrower claims separately.

Personalized

What this means for your dog.

Loading your dog’s context…

Evidence briefing

What Nara knows now.

A bounded position while the full claim-level dossier is still being completed.

What is known

Prospective screening studies of apparently healthy senior and geriatric dogs have found substantial numbers of physical-examination, laboratory, and disease findings that were previously unsuspected. Repeated-screening research likewise demonstrates detection of new findings over time. These studies establish diagnostic yield, not the causal effect of screening on downstream morbidity, quality of life, survival, overdiagnosis, or net benefit.

What is not known

Diagnostic yield is not equivalent to improved patient outcome. Screening value depends on the disease, prevalence, test performance, whether earlier treatment improves outcome, and downstream consequences. Broad panels create opportunities for incidental findings, false-positive results, repeated testing, and potentially unnecessary procedures. Evidence from senior-dog screening cannot automatically define an optimal schedule for younger dogs or all breeds. The umbrella includes interventions with very different evidence bases, including vaccination, parasite prevention, dental prevention, reproductive care, physical examination, laboratory screening, and disease-specific testing.

Current position

Nara considers preventive veterinary care important, but the category should not be given one undifferentiated scientific score. Screening studies show that apparently healthy dogs—particularly older dogs—can have clinically relevant findings that were not previously recognized. Evidence that finding more abnormalities through a generic panel or a fixed testing cadence itself improves lifespan or healthspan is much less established, so screening, vaccination, dental care, parasite control, and other preventive practices should be rated as separate subclaims.

Prospective screening studies of apparently healthy senior and geriatric dogs have found substantial numbers of physical-examination, laboratory, and disease findings that were previously unsuspected. Repeated-screening research likewise demonstrates detection of new findings over time. These studies establish diagnostic yield, not the causal effect of screening on downstream morbidity, quality of life, survival, overdiagnosis, or net benefit.